Anbio Biotechnology Class A Ordinary Shares
Status: Publicly traded
Direct answer
Anbio Biotechnology Class A Ordinary Shares is publicly traded on NASDAQ under the ticker NNNN.
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and...
Can you invest in Anbio Biotechnology Class A Ordinary Shares?
Yes. Anbio Biotechnology Class A Ordinary Shares is publicly traded on NASDAQ under the ticker NNNN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Anbio Biotechnology Class A Ordinary Shares
Detailed equity research is provided by MarketSnap.